Donna Cochener was Promoted as Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel at Neoleukin

Date of management change: April 03, 2023 

What Happened?

Seattle, -based Neoleukin Promoted Donna Cochener as Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel

 

About the Company

Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.

 

About the Person

Donna Cochener is Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel at Neoleukin. Previously, Donna held various senior legal leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Donna Cochener

Title: Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel

Company: Neoleukin

Industry: Biotechnology

imageCurrent Contact Info

 

Email: *********@neoleukin.com 

Phone:.***.***.*44* 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Manchester Ann, Persaud Nadia, Wilhelm Karen, Devaughn Marynell, Bergner Denise, Bryant Timothy, Bayles David, Parr Richard, Gavin Carleigh, Bressler Harold, Heinemann Ryan

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.